Clinical Implication
The Pharmacogenomics Journal (2007) 7, 76–80. doi:10.1038/sj.tpj.6500405; published online 27 June 2006
Clinical implications of genetic polymorphisms on stomach cancer drug therapy
1Experimental and Clinical Pharmacology, CRO-National Cancer Institute, Aviano, Italy
Correspondence: Dr G Toffoli, Experimental and Clinical Pharmacology, CRO-National Cancer Institute, via Pedemontana Occidentale 12, Aviano 33081, Italy. Tel: +39 0434 659667; Fax: +39 0434 659659; E-mail: gtoffoli@cro.it
